COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,395 Articles (22,816 medRxiv, 8,579 bioRxiv)

Most recent first Previous |  Page 254: Articles 2531-2540  | Next

COVID-19 Impact on Patients with Immune-Mediated Rheumatic Disease: A Comparative Study of Disease Activity and Psychological Well-Being Over Six Months
MARQUES, C. D. L., Pinheiro, M., Lopes, J., Ribeiro, S. L. E., Castro, M. V. M., Valadares, L. D. d. A., Ranzolin, A., de Andrada, N. P. B., do Espirito Santo, R. C., Araujo, N. C., Vieira, C. M., Valim, V., Santos, F., da Rocha Junior, L. F., Kakehasi, A. M., Monteiro Gomides Reis, A. P., Torres Neto, E., Pilegii, G., Ferreira, G. A., Mota, L., Monticielo, O., Xavier, R. M.
10.1101/2024.03.18.24304464 — Posted: 2024-03-19
Integrated multiomics implicates dysregulation of ECM and cell adhesion pathways as drivers of severe COVID-associated kidney injury
Anandakrishnan, N., Yi, Z., Sun, Z., Liu, T., Haydak, J., Eddy, S., Jayaraman, P., Defronzo, S., Saha, A., Sun, Q., Dai, Y., Mendoza, A., Mosoyan, G., Wen, H. H., Schaub, J. A., Fu, J., Kehrer, T., Menon, R., Otto, E. A., Godfrey, B., Suarezfarinas, M., Lefferts, S., Twumasi, A., Meliambro, K., Charney, A., Garcia-Sastre, A., Campbell, K., Gusella, L. G., He, J., Miorin, L., Nadkarni, G., Wisnivesky, J. P., Li, H., Kretzler, M., Coca, S., Chan, L., Zhang, W., Azeloglu, E. U.
10.1101/2024.03.18.24304401 — Posted: 2024-03-19
COVID-19-associated acute renal failure in critically ill patients correlates with microthrombosis and renal loss of thrombomodulin
Koskinen, M., Englund, E., Korkut, G. G., Schwarz, A., Jeansson, M.
10.1101/2024.03.18.24304157 — Posted: 2024-03-19
The impact of wildtype SARS-CoV-2 on fatigue and quality of life: prevalence of post COVID-19 condition in a Dutch population-based serosurveillance cohort.
Mutubuki, E. N., van Hagen, C. C. E., Vos, E. R. A., den Hartog, G., van der Klis, F. R. M., van den Wijngaard, C. C., de Melker, H. E., van Hoek, A. J.
10.1101/2024.03.19.24304303 — Posted: 2024-03-19
The Impact of Cognitive Function on Health-Related Quality of Life in Persons with Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine
Kwan, A. T. H., Lakhani, M., Le, G. H., Singh, G., Teopiz, K. M., Guo, Z., Manku, A. S., Rosenblat, J. D., McIntyre, R. S.
10.1101/2024.03.18.24304375 — Posted: 2024-03-19
High transferability of neutralizing antibodies against SARS-CoV-2 to umbilical cord blood in pregnant women with BNT162b2 XBB.1.5 vaccine - a retrospective cohort study
Hayashi, T., Sano, K., Konishi, I.
10.1101/2024.03.18.24304517 — Posted: 2024-03-19
Postpartum suicidal ideation in Austria and Germany during the COVID-19 pandemic
Florea, C., Preiss, J., Angerer, M., Schabus, M.
10.1101/2024.03.15.24304383 — Posted: 2024-03-18
Role of the complement system in Long COVID
Farztdinov, V., Zuehlke, B., Sotzny, F., Steinbeis, F., Seifert, M., Kedor, C., Wittke, K., Tober-Lau, P., Textoris-Taube, K., Ludwig, D., Dierks, C., Bierbaum, D., Sander, L. E., Hanitsch, L. G., Witzenrath, M., Kurth, F., Muelleder, M., Scheibenbogen, C., Ralser, M.
10.1101/2024.03.14.24304224 — Posted: 2024-03-18
Exploring Machine Learning Strategies in COVID-19 Prognostic Modelling: A Systematic Analysis of Diagnosis, Classification and Outcome Prediction
Najjar, R., Hossain, M. Z., Ahmed, K. A., Hasan, M. R.
10.1101/2024.03.17.24304450 — Posted: 2024-03-18
Real-world Nuvaxovid COVID-19 vaccine safety profile after first 100,000 doses in Australia, 2022-2023
Clothier, H. J., Parker, C., Mallard, J. H., Effler, P., Bloomfield, L., Carcione, D., Buttery, J. P.
10.1101/2024.03.17.24304409 — Posted: 2024-03-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).